• Je něco špatně v tomto záznamu ?

Polypharmacy and potentially inappropriate prescribing of benzodiazepines in older nursing home residents

I. Kummer, J. Reissigová, A. Lukačišinová, M. Ortner Hadžiabdić, M. Stuhec, R. Liperoti, H. Finne-Soveri, G. Onder, H. van Hout, D. Fialová

. 2024 ; 56 (1) : 2357232. [pub] 20240604

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013280

INTRODUCTION: Previous research has raised concerns about high prevalence of drug-related problems, polypharmacy and inappropriate benzodiazepine prescribing in nursing homes (NHs) and confirmed lack of studies from Central and South-Eastern Europe. The aim of our study was to determine the prevalence and characteristics of polypharmacy, hyperpolypharmacy and inappropriate benzodiazepine prescribing in NH residents in Croatia. METHODS: Data from 226 older NH residents from five Croatian NHs were collected using the InterRAI Long-Term Care Facilities assessment form. The prevalence and determinants of polypharmacy/hyperpolypharmacy and patterns of inappropriate benzodiazepine prescribing were documented. RESULTS: The prevalence of polypharmacy (49.6%) and hyperpolypharmacy (25.7%) among NH residents was high. In our study, 72.1% of NH residents were prescribed at least one psychotropic agent, 36.7% used 2-3 psychotropics and 6.6% used 4+ psychotropics. Among benzodiazepine users (55.8%), 28% of residents were prescribed benzodiazepines in higher than recommended geriatric doses, 75% used them for the long term and 48% were prescribed concomitant interacting medications. The odds of being prescribed polypharmacy/hyperpolypharmacy were significantly higher for older patients with polymorbidity (6+ disorders, proportional odds ratio (POR) = 19.8), type II diabetes (POR = 5.2), ischemic heart disease (POR = 4.6), higher frailty (Clinical Frailty Scale (CFS ≥5); POR = 4.3) and gastrointestinal problems (POR = 4.8). CONCLUSIONS: Our research underscores the persistent challenge of inappropriate medication use and drug-related harms among older NH residents, despite existing evidence and professional campaigns. Effective regulatory and policy interventions, including the implementation of geriatrician and clinical pharmacy services, are essential to address this critical issue and ensure optimal medication management for vulnerable NH populations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013280
003      
CZ-PrNML
005      
20240905133952.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/07853890.2024.2357232 $2 doi
035    __
$a (PubMed)38833339
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kummer, Ingrid $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, The Czech Republic $1 https://orcid.org/0000000302051576
245    10
$a Polypharmacy and potentially inappropriate prescribing of benzodiazepines in older nursing home residents / $c I. Kummer, J. Reissigová, A. Lukačišinová, M. Ortner Hadžiabdić, M. Stuhec, R. Liperoti, H. Finne-Soveri, G. Onder, H. van Hout, D. Fialová
520    9_
$a INTRODUCTION: Previous research has raised concerns about high prevalence of drug-related problems, polypharmacy and inappropriate benzodiazepine prescribing in nursing homes (NHs) and confirmed lack of studies from Central and South-Eastern Europe. The aim of our study was to determine the prevalence and characteristics of polypharmacy, hyperpolypharmacy and inappropriate benzodiazepine prescribing in NH residents in Croatia. METHODS: Data from 226 older NH residents from five Croatian NHs were collected using the InterRAI Long-Term Care Facilities assessment form. The prevalence and determinants of polypharmacy/hyperpolypharmacy and patterns of inappropriate benzodiazepine prescribing were documented. RESULTS: The prevalence of polypharmacy (49.6%) and hyperpolypharmacy (25.7%) among NH residents was high. In our study, 72.1% of NH residents were prescribed at least one psychotropic agent, 36.7% used 2-3 psychotropics and 6.6% used 4+ psychotropics. Among benzodiazepine users (55.8%), 28% of residents were prescribed benzodiazepines in higher than recommended geriatric doses, 75% used them for the long term and 48% were prescribed concomitant interacting medications. The odds of being prescribed polypharmacy/hyperpolypharmacy were significantly higher for older patients with polymorbidity (6+ disorders, proportional odds ratio (POR) = 19.8), type II diabetes (POR = 5.2), ischemic heart disease (POR = 4.6), higher frailty (Clinical Frailty Scale (CFS ≥5); POR = 4.3) and gastrointestinal problems (POR = 4.8). CONCLUSIONS: Our research underscores the persistent challenge of inappropriate medication use and drug-related harms among older NH residents, despite existing evidence and professional campaigns. Effective regulatory and policy interventions, including the implementation of geriatrician and clinical pharmacy services, are essential to address this critical issue and ensure optimal medication management for vulnerable NH populations.
650    _2
$a lidé $7 D006801
650    12
$a pečovatelské domovy $x statistika a číselné údaje $7 D009735
650    12
$a polypharmacy $7 D019338
650    12
$a benzodiazepiny $x terapeutické užití $x škodlivé účinky $x aplikace a dávkování $7 D001569
650    12
$a nevhodné předepisování $x statistika a číselné údaje $7 D057970
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a senioři $7 D000368
650    _2
$a domovy pro seniory $x statistika a číselné údaje $7 D006707
650    _2
$a prevalence $7 D015995
650    _2
$a psychotropní léky $x terapeutické užití $x škodlivé účinky $7 D011619
650    _2
$a lékařská praxe - způsoby provádění $x statistika a číselné údaje $x normy $7 D010818
651    _2
$a Chorvatsko $x epidemiologie $7 D017523
655    _2
$a časopisecké články $7 D016428
700    1_
$a Reissigová, Jindra $u Department of Statistical Modelling, Institute of Computer Science of the Czech Academy of Sciences, Prague, The Czech Republic $1 https://orcid.org/000000025402699X
700    1_
$a Lukačišinová, Anna $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, The Czech Republic $1 https://orcid.org/0000000164615977
700    1_
$a Ortner Hadžiabdić, Maja $u Center for Applied Pharmacy, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia $1 https://orcid.org/0000000315789764
700    1_
$a Stuhec, Matej $u Department of Pharmacology, Faculty of Medicine Maribor, University of Maribor, Maribor, Slovenia $u Department of Clinical Pharmacy, Ormoz Psychiatric Hospital, Ormoz, Slovenia $1 https://orcid.org/0000000159096930
700    1_
$a Liperoti, Rosa $u Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
700    1_
$a Finne-Soveri, Harriet $u National Institute for Health and Welfare, Helsinki, Finland $1 https://orcid.org/0000000188361860
700    1_
$a Onder, Graziano $u Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy $1 https://orcid.org/0000000334004491
700    1_
$a van Hout, Hein $u Departments of General Practice and Medicine for Older People, Amsterdam University Medical Center, location Vrije Universiteit, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands $1 https://orcid.org/0000000224954808
700    1_
$a Fialová, Daniela $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, The Czech Republic $u Department of Geriatrics and Gerontology, 1st Faculty of Medicine, Charles University, Prague, The Czech Republic $1 https://orcid.org/0000000156389690
773    0_
$w MED00009195 $t Annals of medicine $x 1365-2060 $g Roč. 56, č. 1 (2024), s. 2357232
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38833339 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133946 $b ABA008
999    __
$a ok $b bmc $g 2143231 $s 1225146
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 56 $c 1 $d 2357232 $e 20240604 $i 1365-2060 $m Annals of medicine $n Ann Med $x MED00009195
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Možnosti archivace